Logo image of IFMK

Ifresh Inc (IFMK) Stock Fundamental Analysis

USA - NASDAQ:IFMK -

0.4901
-0.67 (-57.75%)
Last: 11/22/2021, 8:15:34 PM
0.46
-0.03 (-6.14%)
After Hours: 11/22/2021, 8:15:34 PM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to IFMK. IFMK was compared to 40 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of IFMK have multiple concerns. IFMK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IFMK has reported negative net income.
IFMK Yearly Net Income VS EBIT VS OCF VS FCFIFMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 5M -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA 0.57%
ROE 3.62%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IFMK Yearly ROA, ROE, ROICIFMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 200 400 600 800 1K

1.3 Margins

Industry RankSector Rank
OM -2.97%
PM (TTM) 0.8%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IFMK Yearly Profit, Operating, Gross MarginsIFMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 10 20

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for IFMK has been increased compared to 1 year ago.
Compared to 1 year ago, IFMK has an improved debt to assets ratio.
IFMK Yearly Shares OutstandingIFMK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 5M 10M 15M
IFMK Yearly Total Debt VS Total AssetsIFMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M

2.2 Solvency

IFMK has an Altman-Z score of 0.44. This is a bad value and indicates that IFMK is not financially healthy and even has some risk of bankruptcy.
IFMK has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.44
ROIC/WACCN/A
WACCN/A
IFMK Yearly LT Debt VS Equity VS FCFIFMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 5M -5M 10M -10M

2.3 Liquidity

IFMK has a Current Ratio of 0.64. This is a bad value and indicates that IFMK is not financially healthy enough and could expect problems in meeting its short term obligations.
IFMK has a Quick Ratio of 0.64. This is a bad value and indicates that IFMK is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.38
IFMK Yearly Current Assets VS Current LiabilitesIFMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

IFMK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.89%, which is quite impressive.
The Revenue has decreased by -5.11% in the past year.
The Revenue has been decreasing by -6.89% on average over the past years.
EPS 1Y (TTM)96.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.36%
Revenue 1Y (TTM)-5.11%
Revenue growth 3Y-11.9%
Revenue growth 5Y-6.89%
Sales Q2Q%22.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IFMK Yearly Revenue VS EstimatesIFMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M 100M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IFMK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IFMK Price Earnings VS Forward Price EarningsIFMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 86.62
IFMK Per share dataIFMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IFMK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Ifresh Inc

NASDAQ:IFMK (11/22/2021, 8:15:34 PM)

After market: 0.46 -0.03 (-6.14%)

0.4901

-0.67 (-57.75%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.21%
Inst Owner Change-1.59%
Ins Owners30.11%
Ins Owner Change0%
Market Cap22.15M
Analysts0
Price TargetN/A
Short Float %1.17%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 1.07
P/tB N/A
EV/EBITDA 86.62
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.09
BVpS0.46
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.57%
ROE 3.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -2.97%
PM (TTM) 0.8%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.38
Altman-Z 0.44
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.11%
Revenue growth 3Y-11.9%
Revenue growth 5Y-6.89%
Sales Q2Q%22.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A